IDEX Biometrics Reports Q1 2025 Revenues of $0.1M and Net Loss of $4.1M

Reuters
21 May
IDEX Biometrics Reports Q1 2025 Revenues of $0.1M and Net Loss of $4.1M

Idex Biometrics ASA has released its first quarter 2025 financial results, reporting revenues of $0.1 million during the quarter. The company experienced a net loss of $4.1 million. Ordinary operating expenses were registered at $2.4 million, and the cash balance as of 31 March 2025 was $1.1 million. Significant business updates include the announcement of a new strategy on 11 March 2025, aimed at transforming the market approach for its technology and products. Anders Storbråten has been appointed as the new CEO. The company has secured a new debt facility of NOK 30 million, which has been converted to shares, and successfully renegotiated its convertible bond with Heights. Operational improvements are underway, targeting a quarterly run rate for operating expenses between $1.5 million and $1.7 million by the end of Q3 2025. Additionally, Idex Biometrics received a production order in Japan from its manufacturing partner Beautiful Card Corporation, valued at approximately USD 50,000, and an order from DigAware for delivering biometric sensor solutions for access cards. The company also received an order for IDEX Pay biometric cards for VISA in the Middle East & Africa region, totaling 10,000 units. KONA I was granted a Mastercard Letter of Approval for IDEX Pay biometric cards. A subsequent offering was launched, allowing investors to participate under the same terms as shareholders involved in the debt conversion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Idex Biometrics ASA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW1001097965-en) on May 21, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10